The stock of Annovis Bio Inc (ANVS) has seen a -21.11% decrease in the past week, with a -58.05% drop in the past month, and a -51.36% decrease in the past quarter. The volatility ratio for the week is 11.96%, and the volatility levels for the past 30 days are at 25.83% for ANVS.. The simple moving average for the past 20 days is -50.23% for ANVS’s stock, with a -53.76% simple moving average for the past 200 days.
Is It Worth Investing in Annovis Bio Inc (NYSE: ANVS) Right Now?
The 36-month beta value for ANVS is also noteworthy at 1.74. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ANVS is 8.14M, and at present, short sellers hold a 17.85% of that float. The average trading volume of ANVS on May 09, 2024 was 457.52K shares.
ANVS) stock’s latest price update
Annovis Bio Inc (NYSE: ANVS)’s stock price has dropped by -9.91 in relation to previous closing price of 5.35. Nevertheless, the company has seen a loss of -21.11% in its stock price over the last five trading days. Reuters reported 2024-04-29 that Annovis Bio said on Monday that its Alzheimer’s treatment showed significantly higher improvement in cognition in Alzheimer’s patients during a mid-stage trial.
Analysts’ Opinion of ANVS
Many brokerage firms have already submitted their reports for ANVS stocks, with Canaccord Genuity repeating the rating for ANVS by listing it as a “Buy.” The predicted price for ANVS in the upcoming period, according to Canaccord Genuity is $36 based on the research report published on December 29, 2023 of the previous year 2023.
Maxim Group, on the other hand, stated in their research note that they expect to see ANVS reach a price target of $150, previously predicting the price at $45. The rating they have provided for ANVS stocks is “Buy” according to the report published on July 07th, 2021.
ANVS Trading at -51.81% from the 50-Day Moving Average
After a stumble in the market that brought ANVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.57% of loss for the given period.
Volatility was left at 25.83%, however, over the last 30 days, the volatility rate increased by 11.96%, as shares sank -58.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -50.77% lower at present.
During the last 5 trading sessions, ANVS fell by -21.11%, which changed the moving average for the period of 200-days by -62.34% in comparison to the 20-day moving average, which settled at $9.34. In addition, Annovis Bio Inc saw -74.22% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ANVS
The total capital return value is set at -4.21. Equity return is now at value -546.40, with -243.15 for asset returns.
Currently, EBITDA for the company is -45.04 million with net debt to EBITDA at 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.39.
Conclusion
In summary, Annovis Bio Inc (ANVS) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
